MedPath

Impact of multiple micronutrients fortified Oral Nutrition Supplements on physical growth, strength and cognition in School Aged Children.

Not Applicable
Conditions
Health Condition 1: E46- Unspecified protein-calorie malnutrition
Registration Number
CTRI/2024/08/071861
Lead Sponsor
Hindustan Unilever Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Normal and mildly malnourished children with BMI-for-age percentiles [between 3rd to 25th percentile (-1.881) to (-0.674) z-score] by calculating as per WHO 5-19 years Growth Reference will be included

2.Screening for anemia will be done to include all children with hemoglobin =8 mg/dl

3.Children = 6 years to = 16 years will be included. (25-30 children per age). Stratification of pubertal (10 -15+ years) and prepubertal (6-9+ years) will be done later. Both boys and girls will be included

4.Children should not be lactose intolerant /have lactose sensitivity and be comfortable to have milk daily.

[0 – (-1 SD) are normal children; (-1 to -1.9 SD) is defined as mild malnutrition; [-2 to -2.9 SD) is defined as moderate malnutrition; [(= -3) is defined as severe malnutrition].

[mild anaemia defined as 11 – 11.49 and 11 – 11.99 mg/dl for children 5-11 years and 12-14 years respectively; moderate anaemia defined as 8 - 10.99 mg/dl for children 5-11 years and 12-14 years respectively]

Exclusion Criteria

Children will be excluded at the time of screening, if they had been diagnosed or were known to:

1.be lactose intolerant and galactosaemic

2.be allergic or intolerant to wheat / any other cereal

3.have a current acute or chronic infection including but not restricted to respiratory infection, diarrhoea, Hepatitis B or C, HIV infection or tuberculosis.

4.have severe gastrointestinal disorders including celiac disease, short bowel syndrome, pancreatic insufficiency, or cystic fibrosis; have a diagnosis of neoplastic, renal, hepatic or cardiovascular disease, hormonal or metabolic disorders, congenital disease or genetic disorders such as atrial or ventricular wall defects, or Down’s syndrome, infantile anorexia nervosa, developmental disability, including physical disorders such as cerebral palsy, or developmental delay.

5.diagnosed with disorders of haemoglobin structure, function, or synthesis according to medical records or parent/guardian report, or

6.have been diagnose with ADHD, any form of delayed / impaired cognitive development, delayed developmental milestones, or is on any form of medication for other cognitive conditions.

7.have had a clinically significant nutritional deficiency requiring specific treatment with another similar nutritional supplement (other than the study product) or

8.have any other clinically significant medical condition, which, in the investigator’s opinion, made the child unsuitable for inclusion in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the efficacy of two high protein-micronutrient fortified drinks on physical growth of school children and adolescents as assessed by BMI-for-age percentilesTimepoint: 6 Months
Secondary Outcome Measures
NameTimeMethod
To assess the efficacy of two high protein micronutrient fortified drinks on school children (6 – 16 years) as assessed by <br/ ><br>Anthropometric parameters <br/ ><br>1) height-for-age <br/ ><br>2) (weight, height, MUAC, waist circumference, Tricep skinfold) <br/ ><br>Body composition <br/ ><br>3) Bio Impedance Analysis (BIA) <br/ ><br>4) DEXA (in a sub sample) <br/ ><br>5)bone mineral content (BMC DEXA <br/ ><br>6) bone mineral density (BMD) by DEXA. <br/ ><br>7) muscle mass by DEXA. <br/ ><br>8) hand grip strength by hand dynamometer <br/ ><br>9) cognitive function by CANTAB battery of testsTimepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath